Drug approval: Mosunetuzumab - third-line therapy in follicular lymphoma

被引：1
|
作者：
Gondran, Camille [1 ]
Ysebaert, Loic [1 ]
机构：
[1] Inst Univ Canc Toulouse, Serv dh matol, F-31100 Toulouse, France
来源：
BULLETIN DU CANCER | 2022年 / 109卷 / 11期
关键词：
Follicular lymphoma; Mosunetuzumab; Bi-specific antibody CD20-CD3; Cytokine release syndrome;
D O I：
10.1016/j.bulcan.2022.07.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1105 / 1106
页数：2
相关论文
共 50 条
  • [21] A multi-center retrospective analysis of patients with relapsed/refractory follicular lymphoma after third-line chemotherapy
    Fuji, Shigeo
    Tada, Yuma
    Nozaki, Kenji
    Saito, Hideaki
    Ozawa, Takayuki
    Kida, Toru
    Kosugi, Satoru
    Sugahara, Hiroyuki
    Ikeda, Hirokazu
    Hashimoto, Koji
    Karasuno, Takahiro
    Ueda, Shuji
    Ishikawa, Jun
    Shibayama, Hirohiko
    ANNALS OF HEMATOLOGY, 2020, 99 (09) : 2133 - 2139
  • [22] A multi-center retrospective analysis of patients with relapsed/refractory follicular lymphoma after third-line chemotherapy
    Shigeo Fuji
    Yuma Tada
    Kenji Nozaki
    Hideaki Saito
    Takayuki Ozawa
    Toru Kida
    Satoru Kosugi
    Hiroyuki Sugahara
    Hirokazu Ikeda
    Koji Hashimoto
    Takahiro Karasuno
    Shuji Ueda
    Jun Ishikawa
    Hirohiko Shibayama
    Annals of Hematology, 2020, 99 : 2133 - 2139
  • [23] Treatment Regimens and Clinical Outcomes Among Follicular Lymphoma Patients Treated with Third-Line Therapy in the United States: A Real-World EHR Study
    Dai, Dong
    Heo, Ji Haeng
    Rava, Andrew
    Jousseaume, Etienne
    Ramos, Roberto
    Bollu, Vamsi
    BLOOD, 2021, 138
  • [24] Third-line rescue therapy for Helicobacter pylori infection
    Cianci, Rossella
    Montalto, Massimo
    Pandolfi, Franco
    Gasbarrini, Giovan Battista
    Cammarota, Giovanni
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (15) : 2313 - 2319
  • [25] A phase 2 trial of mosunetuzumab with lenalidomide augmentation as first-line therapy for follicular (FL) and marginal zone lymphoma (MZL).
    Olszewski, Adam J.
    Huntington, Scott F.
    Ollila, Thomas
    Pelcovits, Ari
    McMahon, Jessica B.
    Yakirevich, Inna
    Sturtevant, Ashlee
    Chorzalska, Anna
    Morgan, John
    Dubielecka, Patrycja
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Third-line Therapy for metastatic Renal cell carcinoma
    Rexer, H.
    ONKOLOGE, 2011, 17 (12): : 1161 - 1162
  • [27] Omalizumab as Third-Line Therapy for Urticaria During Pregnancy
    Ensina, L. F.
    Cusato-Ensina, A. P.
    Camelo-Nunes, I. C.
    Sole, D.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2017, 27 (05) : 326 - 327
  • [28] Third-line rescue therapy for Helicobacter pylori infection
    Rossella Cianci
    Massimo Montalto
    Franco Pandolfi
    Giovan Battista Gasbarrini
    Giovanni Cammarota
    World Journal of Gastroenterology, 2006, (15) : 2313 - 2319
  • [29] Third-line Therapy for metastatic Renal Cell Carcinoma
    Rexer, H.
    UROLOGE, 2011, 50 (10): : 1319 - 1321
  • [30] HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe
    Chimbetete, Cleophas
    Katzenstein, David
    Shamu, Tinei
    Spoerri, Adrian
    Estill, Janne
    Egger, Matthias
    Keiser, Olivia
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (02):
12345